This inventor holds 1 USPTO granted patent. Top assignee: Compugen Ltd. Corporation. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Innovations by Anat David
Introduction
Anat David is a notable inventor based in Givatayim, Israel. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid sequences. His work has implications for understanding human kallikrein variants, which are important in various biological processes.
Latest Patents
Anat David holds a patent for an isolated nucleic acid sequence, specifically an alternative splice variant of the human kallikrein-2 gene (KLK-2). This patent, which is identified as SEQ ID NO:6, includes an expression vector containing the splice variant and a host cell transfected by the expression vector. The nucleic acid is useful for determining the level of nucleic acid sequences of human kallikrein variants in biological samples. He has 1 patent to his name.
Career Highlights
Anat David is associated with Compugen Ltd., a corporation that focuses on innovative solutions in the field of biotechnology. His work at Compugen has allowed him to explore and develop groundbreaking technologies that contribute to advancements in medical research.
Collaborations
Anat has collaborated with several talented individuals in his field, including Liat Mintz and Kinneret Savitzky. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Anat David's contributions to biotechnology through his patent and work at Compugen Ltd. highlight the importance of innovation in understanding complex biological systems. His efforts continue to pave the way for future advancements in the field.